11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension

Hardy, RS, Botfield, H, Markey, K, Mitchell, JL, Alimajstorovic, Z, Westgate, CSJ, Sagmeister, M, Fairclough, RJ, Ottridge, RS, Yiangou, A, Storbeck, K-HH, Taylor, AE, Gilligan, LC, Arlt, W, Stewart, PM, Tomlinson, JW, Mollan, SP, Lavery, GG ORCID: https://orcid.org/0000-0001-5794-748X and Sinclair, AJ, 2021. 11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. The Journal of Clinical Endocrinology and Metabolism, 106 (1), pp. 174-187. ISSN 0021-972X

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	The Journal of Clinical Endocrinology and Metabolism
Creators:	Hardy, R.S., Botfield, H., Markey, K., Mitchell, J.L., Alimajstorovic, Z., Westgate, C.S.J., Sagmeister, M., Fairclough, R.J., Ottridge, R.S., Yiangou, A., Storbeck, K.-H.H., Taylor, A.E., Gilligan, L.C., Arlt, W., Stewart, P.M., Tomlinson, J.W., Mollan, S.P., Lavery, G.G. and Sinclair, A.J.
Publisher:	The Endocrine Society
Date:	January 2021
Volume:	106
Number:	1
ISSN:	0021-972X
Identifiers:	Number Type 10.1210/clinem/dgaa766 DOI 1532219 Other
Divisions:	Schools > School of Science and Technology
Record created by:	Laura Ward
Date Added:	25 Mar 2022 10:48
Last Modified:	25 Mar 2022 10:48
URI:	https://irep.ntu.ac.uk/id/eprint/45959

Actions (login required)

Edit View

Statistics

Views

Downloads